Saline Breast Implant Makers Must Submit PMAs By Nov. 17, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of saline breast implants have until Nov. 17 to file either a premarket approval application, product development protocol or an investigational device exemption for their products or remove them from commercial distribution, FDA says in an Aug. 19 final rule.